The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH
Open accessAbstract
Acidic extracellular pH (pHe) is a typical attribute of a tumor microenvironment, which has an impact on cancer development and treatment outcome. It was believed to result from an accumulation of lactic acid excessively produced by glycolysis. However, metabolic profiles of glycolysis-impaired tumors have revealed that CO2 is a significant source of acidity, thereby indicating a contribution of carbonic anhydrase (CA). The tumor-associated CA IX isoform is the best candidate, because its extracellular enzyme domain is highly active, expression is induced by hypoxia and correlates with poor prognosis. This study provides the first evidence for the role of CA IX in the control of pHe. We show that CA IX can acidify the pH of the culture medium in hypoxia but not in normoxia. This acidification can be perturbed by deletion of the enzyme active site and inhibited by CA IX-selective sulfonamides, which bind only to hypoxic cells containing CA IX. Our findings suggest that hypoxia regulates both expression and activity of CA IX in order to enhance the extracellular acidification, which may have important implications for tumor progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Švastová and others showed that medium deoxygenation in cell cultures of human cancer cell lines induced the expression and activity of carbonic anhydrases, which resulted in enhanced acidification of the culture medium (Švastová et al., 2004).”
From Toward Best Practices for Controlling Mammalian Cell Culture Environments (2022) · cites this paper as Švastová et al., 2004
Experimental — accuracy not yet measuredIn the citing paper
“Expression of carbonic anhydrases, in particular the CAIX isoform, is elevated during hypoxia (Svastova et al., 2004).”
From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Svastova et al., 2004
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Supuran, C. T., Scozzafava, A., & Casini, A. (2002) · Medicinal Research Reviews · doi:10.1002/med.10025 · Cited by 1,477
Self-citationHypoxia-inducible expression of tumor-associated carbonic anhydrases.
Wykoff, C. C., Beasley, N. J. P., Watson, P. H., Turner, K., Pastorek, J., Sibtain, A., Wilson, G. D., Turley, H., Talks, K., Maxwell, P. H., et al. (2000) · PubMed · Cited by 1,260
Self-citationCauses and consequences of tumour acidity and implications for treatment
Stubbs, M., McSheehy, P. M. J., Griffiths, J. R., & Bashford, C. L. (2000) · Molecular Medicine Today · doi:10.1016/s1357-4310(99)01615-9 · Cited by 781
Acidic pH enhances the invasive behavior of human melanoma cells
Mart�nez-Zaguil�n, R., Seftor, E. A., Seftor, R. E. B., Chu, Y.-W., Gillies, R. J., & Hendrix, M. J. C. (1996) · Clinical & Experimental Metastasis · doi:10.1007/bf00121214 · Cited by 507
Fukumura, D., Xu, L., Chen, Y., Gohongi, T., Seed, B., & Jain, R. K. (2001) · PubMed · Cited by 438
Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism.
Helmlinger, G., Sckell, A., Dellian, M., Forbes, N. S., & Jain, R. K. (2002) · PubMed · Cited by 417
Ivanov, S. V., Kuzmin, I., Wei, M.-H., Pack, S., Geil, L., Johnson, B. E., Stanbridge, E. J., & Lerman, M. I. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12596 · Cited by 394
Opavský, R., Pastoreková, S., Zelnı́k, V., Gibadulinová, A., Stanbridge, E. J., Závada, J., Kettmann, R., & Pastorek, J. (1996) · Genomics · doi:10.1006/geno.1996.0223 · Cited by 383
Self-citationSterling, D., Reithmeier, R. A. F., & Casey, J. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105959200 · Cited by 367
Carbonic Anhydrase: Its Inhibitors and Activators
Supuran, C. T., Scozzafava, A., & Conway, J. D. (2007) · Medical Entomology and Zoology · Cited by 349
Self-citation
Flagged first, then by citations
1 of the 32 references couldn’t be matched to a known paper.
Research works printed but not linked: 7
- Fukumura D., 2001, Cancer Res, 61, 6020
- Helmlinger G., 2002, Clin. Cancer Res, 8, 1284
- Pastorek J., 1994, Oncogene, 9, 2788
- Wykoff C., 2000, Cancer Res, 60, 7075
- 10.1021/jm990479 · DOI
- Semenza G.L., 2003, Nat. Rev, Cancer, 3, 721
- Teicher B.A., 1993, Anticancer Res, 13, 1549
Cited by
Sorted by citations
Items 701–800 of 827
Cormerais, Y. (2016) · theses.fr (ABES) · doi:10.70675/94cc6971z3a1dz454fzb65dzf153dc0a3a05
Bioreductive Activated Prodrugs to Target Tumor Hypoxia
Anduran, E. (2022) · theses.fr (ABES) · doi:10.70675/56ba8d97z5a2ez4c08za166z0250ebfc0763
Thornell, I. M., Michenkova, M., Taki, S., Bevensee, M. O., & Boron, W. F. (2026) · Elsevier eBooks · doi:10.1016/b978-0-12-815389-5.00077-0
D’Ambrosio, K., Langella, E., Monti, S. M., Simone, G. D., & Fiore, A. D. (2026) · The Enzymes · doi:10.1016/bs.enz.2026.06.001
Small molecule drug conjugates
Datta, A., Devbhuti, P., Bhattacharya, S., & Patra, R. (2026) · Annual reports in medicinal chemistry · doi:10.1016/bs.armc.2026.07.003
Matiychuk, V. S., Thomas, A., Khropot, O., Drapak, І., Prasad, P., Tambe, S., Chavan, M., Jadhav, P., Lokhande, K. B., Borhade, T., et al. (2026) · Letters in Drug Design & Discovery · doi:10.1016/j.lddd.2026.100629
BindingDB (2012) · UC San Diego · doi:10.7270/q28p61cm
BindingDB (2012) · UC San Diego · doi:10.7270/q2ff3sq6
BindingDB (2009) · UC San Diego · doi:10.7270/q27m07fq
BindingDB (2011) · UC San Diego · doi:10.7270/q2416x9p
BindingDB (2012) · UC San Diego · doi:10.7270/q22z15zw
BindingDB Entry 50038056: Carbonic anhydrases as targets for medicinal chemistry.
BindingDB (2012) · UC San Diego · doi:10.7270/q28916qg
BindingDB (2009) · UC San Diego · doi:10.7270/q2c828v2
BindingDB (2015) · UC San Diego · doi:10.7270/q2x63ph6
BindingDB (2010) · UC San Diego · doi:10.7270/q2kh0n4q
BindingDB (2010) · UC San Diego · doi:10.7270/q298871j
BindingDB (2020) · UC San Diego · doi:10.7270/q2w3808b
BindingDB Entry 50047677: N-Nitrosulfonamides: A new chemotype for carbonic anhydrase inhibition.
BindingDB (2017) · UC San Diego · doi:10.7270/q25q4z1z
Metadata
- Authors
- Švastová, E., Hulı́ková, A., Rafajová, M., Zat'ovičová, M., Gibadulinová, A., Casini, A., Cecchi, A., Scozzafava, A., Supuran, C. T., Pastorek, J., & Pastoreková, S.
- Affiliations
- Slovak Academy of Sciences (SK)
- University of Florence (IT)
- ORCID
- Venue
- FEBS Letters
- Publisher
- Wiley
- Published
- 2004-10-28
- Volume
- 577
- Issue
- 3
- Pages
- 439-445
- ISSN
- 0014-5793 (ISSN-L)
- 1873-3468
- OpenAlex
- W1990331048
- Cited by
- 711
- References
- 32
- Citations by year
- 2026: 10 · 2025: 11 · 2024: 17 · 2023: 31 · 2022: 22 · 2021: 33 · 2020: 37 · 2019: 27 · 2018: 35 · 2017: 39 · 2016: 22 · 2015: 47 · 2014: 46 · 2013: 43 · 2012: 36
- FWCI
- 12.82
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- FEBS Letters (publishedVersion)
- PubMed (publishedVersion)
- Florence Research (University of Florence) (submittedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
- Funders
- Bayer HealthCare
- Vedecká Grantová Agentúra MŠVVaŠ SR a SAV
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Enzyme function and inhibition
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer and biochemical research
- Keywords
- carbonic anhydrase IX, tumor hypoxia, extracellular pH, tumor acidosis, sulfonamide inhibitors, glycolysis, tumor progression
- MeSH terms
- Carbonic Anhydrase IX, Acidosis, Animals, Antigens, Neoplasm, Binding Sites, Carbonic Anhydrases, Cell Line, Cloning, Molecular, Culture Media, Dogs, Enzyme Inhibitors, HeLa Cells, Humans, Hydrogen-Ion Concentration, Isoenzymes, Precipitin Tests, Sulfonamides, Time Factors, Biomarkers, Tumor, Molecular Structure, Cell Hypoxia, Gene Expression Regulation, Neoplastic, Sequence Deletion, Protein Structure, Tertiary, Biotinylation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review